c-Myc Peptide

(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoic acid

H-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-OH; L-alpha-glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl-L-seryl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-aspartyl-L-leucine; L-Leucine, L-α-glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl-L-seryl-L-α-glutamyl-L-α-glutamyl-L-α-aspartyl-; L-Leucine, N-[N-[N-[N-[N-[N-[N-[N2-(N2-L-α-glutamyl-L-glutaminyl)-L-lysyl]-L-leucyl]-L-isoleucyl]-L-seryl]-L-α-glutamyl]-L-α-glutamyl]-L-α-aspartyl]-; L-α-Glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl-L-seryl-L-α-glutamyl-L-α-glutamyl-L-α-aspartyl-L-leucine; c-Myc epitope tag; c-Myc-tag; cMYC tag (synthetic); Myc peptide; Myc-tag; Neuroblastoma suppressor of tumorigenicity 1 (human clone WO2014/074532-SEQID-317); Transcription factor c-myc (fragment); Transcription factor c-myc (synthetic C-terminal epitope)

2918768-02-0 (TFA salt)

≥95%

1.325±0.06 g/cm3

1669.4±65.0°C at 760 mmHg

EQKLISEEDL

Store at -20°C

Soluble in DMSO

InChI=1S/C51H86N12O21/c1-7-26(6)41(63-48(80)32(20-24(2)3)59-43(75)28(10-8-9-19-52)56-44(76)29(12-15-36(54)65)55-42(74)27(53)11-16-37(66)67)50(82)62-35(23-64)49(81)58-30(13-17-38(68)69)45(77)57-31(14-18-39(70)71)46(78)60-33(22-40(72)73)47(79)61-34(51(83)84)21-25(4)5/h24-35,41,64H,7-23,52-53H2,1-6H3,(H2,54,65)(H,55,74)(H,56,76)(H,57,77)(H,58,81)(H,59,75)(H,60,78)(H,61,79)(H,62,82)(H,63,80)(H,66,67)(H,68,69)(H,70,71)(H,72,73)(H,83,84)/t26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,41-/m0/s1

AZCJJJFQQRDOBC-VBFAXUBKSA-N

CCC(C)C(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)N